Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Country's Decision or any other Communication
(DEC)
published: 08 Oct 2004
last updated: 13 Dec 2018
No
Biotechnology Consultation Agency Response Letter BNF No. 000025
EN
13 Jul 1995
Yes
- Decision on LMOs for direct use as food or feed, or for processing (Article 11, LMOs-FFP)
- Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
No
Yes
-
Organization:Calgene Inc. ()Phone:Fax:Email:Website:
Yes
Yes
Yes
- LMOs for direct use as food
- LMOs for direct use as feed
No
Approval of the import and/or use of the LMO(s) without conditions
-
BCH-LMO-SCBD-14780-6 Living Modified Organism CGN-89111-8 - High oleic acid canolaMonsanto (Calgene) | Production of medical or pharmaceutical compounds (human or animal) (Omega-3 fatty acids (e.g. DHA)), Resistance to antibiotics (Kanamycin)
-
BCH-RA-US-114115-1 Risk Assessment generated by a regulatory process Biotechnology Consultation Memorandum of Video-Conference BNF No. 000025CGN-89111-8 - High oleic acid canola | Turnip, Rapeseed, Canola Plant, Oilseed Rape, Rape, BRANA, Resistance to antibiotics, Production of medical or pharmaceutical compounds (human or animal)
- U.S. Food and Drug Administration [ English ]
